Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease

Inflamm Bowel Dis. 2019 Nov 14;25(12):e157-e158. doi: 10.1093/ibd/izz228.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Child
  • Colitis, Ulcerative*
  • Crohn Disease*
  • Gastrointestinal Microbiome*
  • Humans
  • Inflammatory Bowel Diseases*
  • Metabolomics
  • Sphingolipids

Substances

  • Sphingolipids